Effect of the Glucagon‐like Peptide‐1 Analogue Exenatide Extended Release in Cats with Newly Diagnosed Diabetes Mellitus

BACKGROUND: Exenatide extended release (ER) is a glucagon‐like peptide‐1 analogue that increases insulin secretion, inhibits glucagon secretion and induces satiation in humans with type 2 diabetes mellitus. The use of exenatide ER is safe and stimulates insulin secretion in healthy cats. OBJECTIVES:...

Descripción completa

Detalles Bibliográficos
Autores principales: Riederer, A., Zini, E., Salesov, E., Fracassi, F., Padrutt, I., Macha, K., Stöckle, T.M., Lutz, T.A., Reusch, C.E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
SMALL ANIMAL
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913624/
https://www.ncbi.nlm.nih.gov/pubmed/26700409
http://dx.doi.org/10.1111/jvim.13817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913624/
https://www.ncbi.nlm.nih.gov/pubmed/26700409
http://dx.doi.org/10.1111/jvim.13817

Ejemplares similares